glp 1 egfr cut off GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity Diabetic kidney disease: a new
Description
Diabetes Obes Metab 22(4):492500
Although publication bias should always be considered (Jennings & Van Horn, 2012), neuroimaging studies are likely more susceptible to confirmation bias due to high analytical flexibility (Mller et al., 2018)
In this application note, ATCC evaluated the performance of HepatoXcell Pro across multiple culture formats, demonstrating its flexibility and suitability for tailored experimental approaches in liver biology research, disease modelling, drug discovery, and toxicity testing
Furthermore, Faillie et al
J., Reeves, R
